ArticleFrontiers in medicine2025
A study on the risk prediction model for venous thromboembolism in orthopedic inpatients based on machine learning.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- The Caprini score for venous thromboembolism risk assessment: A scoping review of applications, validation, and future directions.Journal of vascular surgery. Venous and lymphatic disorders · 2026Article
- Application of machine learning models in predicting the risk of thromboembolic events in patients with nonvariceal gastrointestinal bleeding.World journal of gastroenterology · 2026Article
- Machine learning-based prediction of postoperative venous thromboembolism in orthopedic surgery using the MIMIC-IV database and external validation.Frontiers in surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To construct a venous thromboembolism (VTE) risk prediction model for orthopedic inpatients using machine learning modeling techniques, identify high-risk patients, and optimize clinical interventions. Methods: This study involved a retrospective analysis of 286 orthopedic inpatients from Nanxishan Hospital of Guangxi Zhuang Autonomous Region (The Second People's Hospital of Guangxi Zhuang Autonomous Region) from January 1, 2022 to December 31, 2022. To ensure patient information security, all data were fully anonymized before access. The collected data included basic information such as gender, age, ethnicity, and body mass index (BMI), lifestyle factors and medical history (including smoking, alcohol use, diabetes, hypertension, and personal and family history of VTE), clinical test results (such as thrombin time, plasma D-dimer, total bilirubin, and urinary protein via dry chemistry), as well as genetic test results related to VTE risk. Feature analysis and data mining were conducted, and eight different machine learning algorithms were used to build the prediction model. The SHapley Additive exPlanation (SHAP) method was used to rank the feature importance and explain the final model. Results: Through a comprehensive evaluation and comparison of eight different machine learning models, the results clearly indicate that the XGBoost model outperforms the others across all performance metrics, achieving the highest accuracy of 0.828 and AUROC of 0.931, significantly surpassing the other models, particularly in prediction accuracy and discriminative ability. Compared to the traditional Caprini scoring model, XGBoost not only shows improvements in accuracy and specificity but also demonstrates a significant increase in Area Under the Curve (AUC), further validating its superior performance in VTE risk prediction. Conclusion: This model can be effectively used for early risk prediction of VTE, helping to reduce the incidence of venous thromboembolism in orthopedic patients. Given its promising results, further validation and wider application of the model in clinical settings are warranted to enhance patient outcomes and improve preventive strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.